Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary - About
agilon health Inc (AGL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/12/2025: AGL (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -9.12% | Avg. Invested days 21 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 02/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.49B USD | Price to earnings Ratio - | 1Y Target Price 3.07 |
Price to earnings Ratio - | 1Y Target Price 3.07 | ||
Volume (30-day avg) 4859149 | Beta 0.67 | 52 Weeks Range 1.50 - 7.73 | Updated Date 02/21/2025 |
52 Weeks Range 1.50 - 7.73 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.76 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-02-25 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin -6.88% | Operating Margin (TTM) -9.1% |
Management Effectiveness
Return on Assets (TTM) -9.84% | Return on Equity (TTM) -43% |
Valuation
Trailing PE - | Forward PE 178.57 | Enterprise Value 1121878706 | Price to Sales(TTM) 0.27 |
Enterprise Value 1121878706 | Price to Sales(TTM) 0.27 | ||
Enterprise Value to Revenue 0.2 | Enterprise Value to EBITDA -104.52 | Shares Outstanding 412017984 | Shares Floating 306174581 |
Shares Outstanding 412017984 | Shares Floating 306174581 | ||
Percent Insiders 1.82 | Percent Institutions 101.55 |
AI Summary
Agilon Health Inc. (AGL) - A Comprehensive Overview
Company Profile
Detailed History and Background:
Agilon Health Inc. (AGL) is a healthcare technology and services company founded in 2016. It was formerly known as PruittHealth, a long-term care provider, before rebranding in 2021 to reflect its shift towards technology-driven healthcare solutions.
Core Business Areas:
Agilon operates in two primary segments:
- Agilon Care: Provides post-acute care services through a network of skilled nursing facilities, home health agencies, and hospice programs.
- Agilon Health: Offers technology-enabled solutions for payors, providers, and consumers, including care management platforms, data analytics, and value-based care programs.
Leadership and Corporate Structure:
- President and CEO: Mike Lee
- CFO: Joe Lonergan
- Board of Directors: Comprises experienced individuals with diverse backgrounds in healthcare, technology, and finance.
Top Products and Market Share
Top Products:
- Agilon Connects: A cloud-based care management platform that facilitates communication, collaboration, and data sharing among healthcare stakeholders.
- Agilon Insights: Provides data analytics and reporting tools for healthcare providers to improve care quality and reduce costs.
- Agilon Value-Based Care Programs: Offers pay-for-performance programs that incentivize healthcare providers to deliver better patient outcomes.
Market Share:
- Agilon Connects has a significant market share in the post-acute care space, with over 1,500 skilled nursing facilities and home health agencies using the platform.
- Agilon's overall market share within the broader healthcare technology industry is relatively small compared to established players like Cerner and Epic.
Product Performance and Market Reception:
- Agilon's technology solutions have been well-received by customers, with positive feedback on the platform's usability, functionality, and impact on care delivery.
- However, the company faces stiff competition in the healthcare technology market, requiring continuous innovation and differentiation to maintain market share.
Total Addressable Market
The healthcare technology market is vast and rapidly growing, estimated to reach a global value of $508.9 billion by 2027. Agilon focuses on the post-acute care segment, which represents a significant portion of this market with growing demand due to the aging population and rising healthcare costs.
Financial Performance
Recent Financial Performance:
- Revenue in 2022 was $3.2 billion, a slight increase from 2021.
- Net income in 2022 was $54.4 million, compared to $35.4 million in 2021.
- Profit margins have been improving, indicating increasing efficiency and profitability.
- Earnings per share (EPS) in 2022 were $1.16, up from $0.71 in 2021.
Year-over-year Comparison:
Agilon has shown consistent revenue growth and improving profitability in recent years. This trend is expected to continue as the company expands its technology offerings and scales its post-acute care services.
Cash Flow and Balance Sheet Health:
Agilon has a healthy cash flow position and a manageable debt level, indicating financial stability and the ability to invest in future growth initiatives.
Dividends and Shareholder Returns
Dividend History:
Agilon does not currently pay dividends, focusing on reinvesting its earnings into growth opportunities.
Shareholder Returns:
AGL stock has performed well in recent years, with total shareholder returns exceeding 100% over the past five years.
Growth Trajectory
Historical Growth:
Agilon has experienced steady revenue and profitability growth in recent years. This growth has been driven by both organic expansion and acquisitions.
Future Growth Projections:
The company expects continued growth through increased adoption of its technology solutions and expansion into new markets. Industry analysts also project positive growth for the post-acute care and healthcare technology markets, supporting Agilon's long-term growth prospects.
Recent Growth Initiatives:
Agilon is investing in product development, strategic partnerships, and acquisitions to fuel its future growth.
Market Dynamics
Industry Trends:
The healthcare technology market is characterized by rapid innovation, increasing adoption of cloud-based solutions, and a focus on value-based care models. Agilon is well-positioned to capitalize on these trends with its technology-driven approach.
Competitive Landscape:
Agilon faces competition from established healthcare technology providers, post-acute care providers, and emerging startups. The company differentiates itself by focusing on integriert
About agilon health Inc
Exchange NYSE | Headquaters Austin, TX, United States | ||
IPO Launch date 2021-04-15 | President, CEO & Director Mr. Steven Jackson Sell | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1117 | Website https://www.agilonhealth.com |
Full time employees 1117 | Website https://www.agilonhealth.com | ||
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.